These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 34225962)
1. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease. Wilson H; de Natale ER; Politis M Handb Clin Neurol; 2021; 179():189-205. PubMed ID: 34225962 [TBL] [Abstract][Full Text] [Related]
2. Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease. Schulz J; Pagano G; Fernández Bonfante JA; Wilson H; Politis M Brain; 2018 May; 141(5):1501-1516. PubMed ID: 29701787 [TBL] [Abstract][Full Text] [Related]
3. Nucleus basalis of Meynert neuronal activity in Parkinson's disease. Lee DJ; Milosevic L; Gramer R; Sasikumar S; Al-Ozzi TM; De Vloo P; Dallapiazza RF; Elias GJB; Cohn M; Kalia SK; Hutchison WD; Fasano A; Lozano AM J Neurosurg; 2020 Feb; 132(2):574-582. PubMed ID: 30797189 [TBL] [Abstract][Full Text] [Related]
4. Free-Water Imaging of the Nucleus Basalis of Meynert in Patients With Idiopathic REM Sleep Behavior Disorder and Parkinson Disease. Zhang D; Zhou L; Lu C; Feng T; Liu J; Wu T Neurology; 2024 Apr; 102(7):e209220. PubMed ID: 38489578 [TBL] [Abstract][Full Text] [Related]
5. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology. Nazmuddin M; van Dalen JW; Borra RJH; Stormezand GN; van der Horn HJ; van der Zee S; Boertien J; van Laar T Parkinsonism Relat Disord; 2021 Dec; 93():43-49. PubMed ID: 34784526 [TBL] [Abstract][Full Text] [Related]
7. Clinical and Cerebral Metabolic Changes in Parkinson's Disease With Basal Forebrain Atrophy. Gang M; Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Hasegawa T; Aoki M; Takeda A; Mori E; Suzuki K Mov Disord; 2020 May; 35(5):825-832. PubMed ID: 31971293 [TBL] [Abstract][Full Text] [Related]
8. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment. Crockett RA; Wilkins KB; Aditham S; Brontë-Stewart HM Neurobiol Dis; 2023 Sep; 185():106243. PubMed ID: 37524210 [TBL] [Abstract][Full Text] [Related]
9. Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment. Qiu T; Hong H; Zeng Q; Luo X; Wang X; Xu X; Xie F; Li X; Li K; Huang P; Dai S; Zhang M; Neurobiol Aging; 2023 Dec; 132():198-208. PubMed ID: 37852044 [TBL] [Abstract][Full Text] [Related]
10. Damaged fiber tracts of the nucleus basalis of Meynert in Parkinson's disease patients with visual hallucinations. Hepp DH; Foncke EMJ; Berendse HW; Wassenaar TM; Olde Dubbelink KTE; Groenewegen HJ; D J van de Berg W; Schoonheim MM Sci Rep; 2017 Aug; 7(1):10112. PubMed ID: 28860465 [TBL] [Abstract][Full Text] [Related]
11. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease. Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203 [TBL] [Abstract][Full Text] [Related]
13. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert. Nemy M; Cedres N; Grothe MJ; Muehlboeck JS; Lindberg O; Nedelska Z; Stepankova O; Vyslouzilova L; Eriksdotter M; Barroso J; Teipel S; Westman E; Ferreira D Neuroimage; 2020 May; 211():116607. PubMed ID: 32035186 [TBL] [Abstract][Full Text] [Related]
14. Integrity of the nucleus basalis of meynert and self-reported cognitive dysfunction during wearing-off periods in parkinson's disease. Lench DH; Turner TH; Wetmore E; Rodriguez-Porcel FJ; Revuelta GJ Brain Imaging Behav; 2024 Feb; 18(1):256-261. PubMed ID: 37889445 [TBL] [Abstract][Full Text] [Related]
15. Nucleus basalis of Meynert predicts cognitive changes in isolated REM sleep behavior disorder. Yang A; Li G Sleep Med; 2023 Sep; 109():11-17. PubMed ID: 37393717 [TBL] [Abstract][Full Text] [Related]
16. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis. Hildesheim FE; Benedict RHB; Zivadinov R; Dwyer MG; Fuchs T; Jakimovski D; Weinstock-Guttman B; Bergsland N J Neurol; 2021 Dec; 268(12):4796-4808. PubMed ID: 33997915 [TBL] [Abstract][Full Text] [Related]
17. Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease? Jethwa KD; Dhillon P; Meng D; Auer DP; AJNR Am J Neuroradiol; 2019 Dec; 40(12):2039-2044. PubMed ID: 31727757 [TBL] [Abstract][Full Text] [Related]
18. Nucleus basalis of Meynert predicts cognition after deep brain stimulation in Parkinson's disease. Kübler D; Wellmann SK; Kaminski J; Skowronek C; Schneider GH; Neumann WJ; Ritter K; Kühn A Parkinsonism Relat Disord; 2022 Jan; 94():89-95. PubMed ID: 34896929 [TBL] [Abstract][Full Text] [Related]
19. Meynert nucleus-related cortical thinning in Parkinson's disease with mild cognitive impairment. Rong S; Li Y; Li B; Nie K; Zhang P; Cai T; Mei M; Wang L; Zhang Y Quant Imaging Med Surg; 2021 Apr; 11(4):1554-1566. PubMed ID: 33816191 [TBL] [Abstract][Full Text] [Related]
20. Nucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's disease. Liu AK; Chang RC; Pearce RK; Gentleman SM Acta Neuropathol; 2015 Apr; 129(4):527-40. PubMed ID: 25633602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]